Lionel Laurent, Columnist

Trust in Covid-19 Vaccines Could Turn on a Knife Edge

The race to remove regulatory and legal roadblocks to secure a vaccine could do with some speed bumps.

September 4, 2020 at 8:12 AM UTC

Lionel Laurent is a Bloomberg Opinion columnist writing about the future of money and the future of Europe. Previously, he was a reporter for Reuters and Forbes.

Let’s make sure we get this right.
Photographer: SOPA Images/LightRocket via Getty Images

Provide news feedback or report an error

Site feedback:

Take our Survey

This article is for subscribers only.

Finding a vaccine against Covid-19 that works and can be distributed widely enough to help stop the pandemic is a global priority. Given the urgency, governments are doing all they can to fund research and incentivize firms to ramp up trials — pre-ordering doses, lowering regulatory barriers to market and granting manufacturers immunity from costly future injury-related lawsuits.

But when does the scramble for supply start to look like corner-cutting?